MedTrace Logo

Misoprosotol and Isosorbide Mononitrate for Induction of Second Trimester Abortion

NCT03407521 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-02-28

No results posted yet for this study

Summary

the investigators aimed to study the efficacy and safety of nitric oxide donors when combined with prostaglandins in induction of second trimester abortion expecting that both drugs when used together will be of greater efficiency and associated with less side effects.

the study included 60 women with gestational age between 13weeks+0day and 26weeks+6days indicated for pregnancy termination due to maternal or fetal cause.

Conditions

  • Second Trimester Abortion

Interventions

DRUG

Misoprostol

induction of abortion using misoprostol

DRUG

isosorbide mononitrate

isosorbide mononitrate

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • mohamed ab elsenity, MD · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-12
Primary Completion
2017-10-22
Completion
2017-12-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03407521 on ClinicalTrials.gov